Inclusion Criteria:  Available for the duration of the protocol follow-up; Consent to participate ; Agreed not to participate in another clinical research study until the end of the trial follow-up.  Exclusion Criteria:  Prior history of EVD (self-reported); Previous vaccination with r-VSV-ZEBOV or any other Ebola vaccine (self-reported); Previous administration of Ebola antibody-based PEP; HIV-1 and/or 2 positive serology; Pregnant women (positive pregnancy test); To the opinion of the investigator, any clinically significant acute/chronic condition that would limit the participant's ability to meet the requirements of the study protocol; Immunosuppressive drugs; Participation in another clinical research study within the last 30 days; Allergy to any component of the vaccine or Mabs; Any other reason that, at the investigator's discretion, would compromise the participant's safety and cooperation in the trial.